Trials / Completed
CompletedNCT00592098
2PX (Topical Strontium Chloride Hexahydrate) in Patients With Post-Amputation Stump Pain.
A Double-Blind, Placebo-Controlled Cross-Over Study to Evaluate the Efficacy of 2PX (Topical Strontium Chloride Hexahydrate) in Patients With Persistent, Moderate-to-Severe Lower Limb Post-Amputation Stump Pain.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 22 (estimated)
- Sponsor
- SantoSolve AS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to investigate the analgesic effect of topical strontium chloride in stump pain, and to prospectively determine other efficacy and safety measures of topical strontium chloride in stump pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Strontium chloride hexahydrate | Cutaneous solution, 1 ml dose per 100 sq cm of affected skin area, To be applied twice daily for 28 days. |
| DRUG | Placebo | Cutaneous saline solution, 1 ml dose per 100 sq cm of affected skin area, To be applied twice daily for 28 days. |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2008-01-11
- Last updated
- 2008-01-11
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00592098. Inclusion in this directory is not an endorsement.